Molekule Group, Inc.

Operating margin

−7611.9%

Net margin

−2715.4%

Return on equity

−31.3%

Return on assets

−21.2%

Return on capital (ROCE)

−70.3%

Liabilities / assets

32.4%

Debt / equity

0.48×

Book value / share

$1.42

Revenue growth (YoY)

−63.1%

Net income growth (YoY)

—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Altman Z″ (distress)

1.87grey zone

Accruals / assets

15.3%high accruals

Beneish M-Score

28.53elevated

Piotroski F-Score

2/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

• Delisting / listing-standard noticeOct 5, 2023
• Bankruptcy or receivership · New financial obligation · Debt acceleration / triggering event · Regulation FD disclosureOct 3, 2023
• Other material eventSep 25, 2023
• Costs from exit or disposal · Director / officer change · Other material eventSep 20, 2023
• Other material eventAug 23, 2023
• Results of operationsAug 16, 2023
• Terminated a material agreementAug 14, 2023
• Shareholder voteJun 22, 2023

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.